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The process of labour puts great strain on the mother 
and her foetus with prolonged labour being 
associated with several maternal and fetal 
complications. However, introduction of active 
management of labour has contributed to reduction 
in the incidence of prolonged labour though some 
patients still have episodes of labour dysfunction 
from cervical dystocia often leading to caesarean 
delivery. Shortening of labour duration would 
thereforeminimize maternal and fetal morbidity and 
mortality.
Several spasmolytics have been tried with varied 
1,2
results. Atropine easily crosses the blood brain 
barrier while drovaterine is less effective when 
3
compared with hyoscine. However, hyoscine butyl 
bromide (HBB) has been reported to effectively 
shorten the length of the first stage of labour by 
increasing the rate of cervical dilatation. Parturients 
who had hyoscine in labour also reported significant 
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ABSTRACT
Background: Prolonged labour from cervical dystocia or stasis is one of the common indications for 
caesarean delivery. Hyoscine N-butyl bromide (HBB), an anticholinergic and antispasmodic drug, has been 
found effective in shortening the first stage of labour with no adverse effects on feto-maternal outcomes. 
Case presentations: We present a series of 3 cases with apparent clinical evidence of prolonged labour but 
which later progressed to achieve vaginal delivery following an injection of HBB.
Discussion: Relevant literatures explored revealed the clinical relevance and potential benefits of reviewing 
the use of HBB in our environment.
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INTRODUCTION
pain relief and there has been no associated risk or 
1-4
adverse effects to their babies.  Routine use of HBB 
is absent from our protocol despite the potential 
advantage of significant reduction in the risk of 
prolonged labour.
Potential bene? ts of reduced ? rst stage time include a 
reduction in the incidence of chorioamnionitis, 
neonatal sepsis, and puerperal sepsis, all of which are 
increased in women with prolonged labour. A 
reduced need for repeat doses of opioid analgesia, 
which is associated with neonatal respiratory 
depression, is also a major bene? t of a shorter labour 
process. This is particularly true in regions with 
limiteduse of epidural analgesia and opioid 
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monitored with the aid of a partograph.  A review 
4hours after commencement of oxytocin showed that 
her cervical dilatation remained 4cm despite regular, 
adequate uterine contractions. She had 40mg 
ofHBBintravenously and labour was allowed to 
progress. Twohours later, she achieved cervical 
dilatation of 7cm and in another 2hours, she was fully 
dilated.She eventually had an uneventful vaginal 
delivery of a live female neonate with birth weight of 
3.5kg and APGAR scores of 8 at one minute and 10 at 
5 minutes of life. Both mother and baby had no 
complication and were discharged home the 
following day. Post natal visit at 6 weeks was 
essentially as expected and the mother was referred 
to the family planning clinic while the baby was 
referred to the infant welfare clinic. 
Case 3:Mrs AC is an unbooked 21 years-old 
primigravida admitted in active phase of labour. 
Cervical dilatation on admission was 4cm but uterine 
contract ions were inadequate .  Oxytocin 
augmentation of labour was commenced and a 
review after 4 hours revealed a cervical dilatation of 
5cm despite regular strong uterine contractions. She 
was given intravenous hyoscine bromide 40mg 
slowly with the plan to observe for 2 more hours 
while making arrangement for possible emergency 
caesarean delivery. At this second review, she had 
progressed to cervical dilatation of 8cm and 
subsequently achieved vaginal delivery an hour later. 
Baby weighed 3.2kg at birth and has APGAR scores 
of 8 at the first minute of life and 10 at five minutes. 
Immediate postpartum period was uneventful.
DISCUSSION
The contractility of the myometrium during 
pregnancy is usually diminished to accommodate 
and protect the growing products of conception with 
the cervix forming a tight sphincter to ensure the 
integrity of pregnancy. Close to term, myometrial 
medications are used more frequently. It is believed 
that any intervention which can safely reduce the 
amount of time spent in the painful process of 
parturition will be greatly appreciated by our women.
CASE PRESENTATIONS: The following cases 
are presented to illustrate this discussion.
Case 1: Mrs CA is a 28years old primigravida who 
presented in our facility with an 8-hour history of 
spontaneous onset of labour pains and 6-hour history 
of spontaneous rupture of foetal membranes. Clinical 
examination confirmed full cervical effacement, 
cervical dilatation of 5cm and occurrence of 3 
regular, strong uterine contractions within 
10minutes. The baby's lie was longitudinal and 
presentation was cephalic.
She was allowed to progress in labour but a review in 
4 hours revealed ineffective uterine contractions for 
which an augmentation of labour with oxytocin was 
commenced. A further review 2 hours later 
confirmed that despite good, adequate uterine 
contractions, the cervical dilation was 6cm (0.5cm/ 
hour). She had an intravenous hyoscine 40mg and 
labour was allowed to continue.  She became fully 
dilated 2hrs later and had a spontaneous vaginal 
delivery of a live female neonate with birth weight of 
3.2kg and APGAR score of 8 at one minute and 9 at 
5minutes of life. Both mother and baby had no 
complication and were discharged home the 
following day. Post natal visit at 6 weeks was 
essentially as expected and the mother was referred 
to the family planning clinic while the baby was 
referred to the infant welfare clinic. 
Case 2: Mrs AF is a 25yearsold primiparouslady 
admitted for induction of labour on account of 
postdatism.She had effective cervical ripening with 
intracervical catheter. She was commenced on 
oxytocin induction when the cervix was fully effaced 
and cervical dilatation was 4cm. The labour was 
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the length of the first stage of labour.The mechanism 
by which it acts in the context of labour has not yet 
been elucidated, and the evidence for its efficacy was 
2previously largely anecdotal.
Following intravenous administration, HBB is 
rapidly distributed (half-life = 29 minutes) into the 
tissues. Its onset of action after intravenous dosing is 
10 minutes, peak effect is seen at 20-60 minutes, and 
action lasts for two hours, with an elimination half-
life of 4.8 hours.It does not pass the blood–brain 
barrier, and plasma protein binding is low; 
approximately half of the clearance is via the renal 
system and the main metabolites found in urine have 
no significant clinical action. The advantages of 
intravenous route in a controlled manner are its rapid 
onset of action and bypass of hepatic metabolism. 
The rectal route is also popular for this reason. 
Almost all the studies reviewed reported a 
statistically significant reduction in the duration of 
5 – 12the first stage of labour. Only one study reported no 
difference in the duration of labour but it was 
discovered that the baseline characteristics of the 
patients recruited into the study were different 
statistically.On the other hand however, the duration 
of the second and third stages of labour was similar in 
almost all the groups of women studied implying that 
the action of HBB is primary on the cervix, and not so 
much on promotion of uterine activity.This is an 
important point to consider as it obviates the 
concerns regarding an excessively rapid second 
stage, which can predispose to both maternal 
complications (such as an increased risk for 
lacerations) and neonatal complications (such as 
intracranial haemorrhage from rapid, uncontrolled 
decompression of the foetal head at delivery).
The request for opioid analgesia was significantly 
lower among the study populations compared to the 
control group in tandem with meta-analysis by 
1Rohwer et al  suggesting the possible efficacy of 
HBB in acting as an analgesic in addition to its role in 
activity increases and the cervix undergoes 
biochemical changescalled cervical maturation and 
ripening thereby paving way for cervical dilatation. 
However, the subject of cervical dilatation and 
progress of labour has puzzled obstetricians for a 
long time, with prolonged labour having 
implications for both the mother and the foetus. 
Guided acceleration of labour process is considered 
to be an important factor in reducing maternal 
morbidity as well as the neonatal complications.
For active management of labour, prospective 
detection of departure from normal progress is very 
important, and should be automatically managed by 
augmenting the powers to accelerate progress, 
because this was the only variable open to 
manipulation by the clinician. Apart from uterine 
contraction, cervical dilatation is an important factor 
which determines the duration of labour. Smooth 
muscle relaxants inhibit impulses, in form of spasms, 
that impair effective cervical dilatation and various 
agents have been used to combat cervical muscle 
spasm. Antispasmodics, such as Hyoscine Butyl 
Bromide(HBB) – a quaternary ammonium 
derivative,inhibit cholinergic transmission in the 
abdominal and pelvic parasympathetic ganglia, with 
consequent relief of spasm in the smooth muscles of 
gastrointestinal, biliary, urinary tract and female 
genital organs, especially the cervico-uterine plexus 
thus aiding cervical dilatation and can therefore be 
used for enhancing cervical ripening and shortening 
stages of labour.
HBB, in form of Buscopan®, has been found useful 
in shortening the duration of labour in several 
5-8
studies . Whereas its analgesic properties are 
probably negligible in the context of labour, its value 
lies in the reduced time spent in the ? rst stage, and 
consequently the reduced overall time spent in pain 
by the parturient. Literature review revealedvery few 
studies relating to HBB and its use in labour with 
most of them confirming its effectiveness in reducing 
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12,14labour while others reported the ineffectiveness of 
rectal HBB regarding its effect in shortening the first 
6stage of labour.
CONCLUSION
It is obvious from this review that HBB has the 
potential toshorten the first stage of labour. This 
isparticularly useful information for regions with 
limited availability of epidural analgesia.It is 
important to note that any intervention that can safely 
reduce the amount of time spent in the painful 
process of parturition will be greatly appreciated by 
women. The reduction in first stage duration may 
also prove to be of particular importance for women 
w i t h  a  b o r d e r l i n e  p l a c e n t a l  r e s e r v e ,  
oligohydramnios, or risk of prolonged variable 
deceleration during labor, as may be encountered in 
women with hypertension (both chronic and 
gestational) or sickle cell anaemia, which is still 
common in our population. HBB is better in 
achieving the end result and hence it can be used in 
modern obstetrics to relieve spasm and to hasten the 
rate of cervical dilatation, thereby promoting safe 
delivery.Large, multi-centre well-designed studies in 
this regard will be highly beneficial.
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